Late Effects in 164 Patients With Rhabdomyosarcoma of the Bladder/Prostate Region: A Report From the International Workshop

Journal of Urology

Volumn 176, Issue 5, 2006, Pages 2190-2195

  Raney, Beverly ^a   Anderson, James ^b   Jenney, Meriel ^c   Arndt, Carola ^e   Brecht, Ines ^f   Carli, Modesto ^g   Bisogno, Gianni ^g   Oberlin, Odile ^h   Rey, Annie ^h   Treuner, Jörn ^f   Ullrich, Fred ^b   Stevens, Michael ^d  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^c CARDIFF UNIVERSITY   (United Kingdom)

^d Royal Hospital for Children   (United Kingdom)

^e MAYO CLINIC   (United States)

^f OLGAHOSPITAL   (Germany)

^g UNIVERSITY HOSPITAL OF PADOVA   (Italy)

^h INSTITUT GUSTAVE ROUSSY   (France)

Author keywords

bladder neoplasms; follow up studies; pediatrics; prostatic neoplasms; rhabdomyosarcoma

Indexed keywords

CREATININE; NITROGEN; UREA;

AGE DISTRIBUTION; ARTICLE; BLADDER FUNCTION; BLADDER TUMOR; CANADA; CHILD; COURSE EVALUATION; CREATININE CLEARANCE; CYSTECTOMY; FEMALE; FOLLOW UP; FRANCE; GERMANY; HEMATURIA; HUMAN; HYDRONEPHROSIS; ITALY; MAJOR CLINICAL STUDY; MALE; MEDICAL ASSESSMENT; MEDICAL RECORD; MICTURITION DISORDER; NOCTURNAL ENURESIS; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROSTATE TUMOR; PROSTATECTOMY; RHABDOMYOSARCOMA; SAMPLE SIZE; SURGICAL PATIENT; TREATMENT OUTCOME; UNITED KINGDOM; UNITED STATES; UREA BLOOD LEVEL; URINARY DIVERSION; URINARY TRACT INFECTION; URINE INCONTINENCE; URODYNAMICS; UROLITHIASIS; VESICOURETERAL REFLUX; WESTERN EUROPE;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; HUMANS; INFANT; MALE; PROSTATIC NEOPLASMS; RHABDOMYOSARCOMA; TIME FACTORS; URINARY BLADDER NEOPLASMS;

EID: 33750324722     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.juro.2006.07.064     Document Type: Article

References (20)

1. Ortega J.A. A therapeutic approach to childhood pelvic rhabdomyosarcoma without pelvic exenteration. J Pediatr 94 (1979) 205
2. Kaplan W.E., Firlit C.F., and Berger R.M. Genitourinary rhabdomyosarcoma. J Urol 130 (1983) 116
3. Ghavimi F., Herr H., Jereb B., and Exelby P.R. Treatment of genitourinary rhabdomyosarcoma in children. J Urol 132 (1984) 313
4. Loughlin K.R., Retik A.B., Weinstein H.J., Colodny A.H., Shamberger R.C., Delorey M., et al. Genitourinary rhabdomyosarcoma in children. Cancer 63 (1989) 1600
5. Heij H.A., Vos A., de Kraker J., and Voute P.A. Urogenital rhabdomyosarcoma in children: is a conservative surgical approach justified?. J Urol 150 (1993) 165
6. Hicks B.A., Hensle T.W., Burbige K.A., and Altman R.P. Bladder management in children with genitourinary sarcoma. J Pediatr Surg 28 (1993) 1019
7. Atra A., Ward H.C., Aitken K., Boyle M., Dicks-Mireaux C., Duffy P.G., et al. Conservative surgery in multimodal therapy for pelvic rhabdomyosarcoma in children. Br J Cancer 70 (1994) 1004
8. Raney Jr. R.B., Gehan E.A., Hays D.M., Tefft M., Newton Jr. W.A., Haeberlen V., et al. Primary chemotherapy with or without radiation and/or surgery for children with localized sarcoma of the bladder, prostate, vagina, uterus, and cervix: a comparison of the results in Intergroup Rhabdomyosarcoma Studies I and II. Cancer 66 (1990) 2072
9. Crist W., Gehan E.A., Ragab A.H., Dickman P.S., Donaldson S.S., Fryer C., et al. The third Intergroup Rhabdomyosarcoma Study. J Clin Oncol 13 (1995) 610
10. Arndt C., Rodeberg D., Breitfeld P.P., Raney R.B., Ullrich F., and Donaldson S. Does bladder preservation (as a surgical principle) lead to retaining bladder function in bladder/prostate rhabdomyosarcoma?. Results from Intergroup Rhabdomyosarcoma Study-IV. J Urol 171 (2004) 2396
11. Flamant F., Rodary C., Rey A., Praquin M.T., Sommelet D., Quintana E., et al. Treatment of non-metastatic rhabdomyosarcoma in childhood and adolescence. Results of the second study of the International Society of Paediatric Oncology: MMT84. Eur J Cancer 34 (1998) 1050
12. Stevens M.C.G., Rey A., Bouvet N., Ellershaw C., Flamant F., Habrand J.L., et al. Treatment of nonmetastatic rhabdomyosarcoma in childhood and adolescence: third study of the International Society of Paediatric Oncology-SIOP Malignant Mesenchymal Tumor 89. J Clin Oncol 23 (2005) 2618
13. Carli M., Pastore G., Perilongo G., Grotto P., De Bernardi B., Ceci A., et al. Tumor response and toxicity after single high-dose versus standard five-day divided-dose dactinomycin in childhood rhabdomyosarcoma. J Clin Oncol 6 (1988) 654
14. Carli M., Bisogno G., Guglielmi M., Cecchetto G., De Bernardi B., Donfrancesco A., et al. Improved outcome for children with embryonal rhabdomyosarcoma (RMS): results of the Italian Cooperative Study (ICS). Med Pediatr Oncol 35 (2000) 191
15. Treuner, J. and Dantonello, T.: Unpublished data
16. Treuner J., Brecht I.B., Mattke A.D., Harms D., Gadner H., Kazanowska B., et al. Interim report of the CWS-96 Study: results of the treatment for soft tissue sarcomas in childhood. Med Pediatr Oncol 41 (2003) 278
17. Raney B., Ensign L.G., Foreman J., Khan F., Newton W., and Ortega J. Renal toxicity of ifosfamide in pilot regimens of the Intergroup Rhabdomyosarcoma Study for patients with gross residual tumor. Am J Pediatr Hematol Oncol 16 (1994) 286
18. Raney Jr. B., Heyn R., Hays D.M., Tefft M., Newton Jr. W.A., Wharam M., et al. Sequelae of treatment in 109 patients followed for 5 to 15 years after diagnosis of sarcoma of the bladder and prostate. A report from the Intergroup Rhabdomyosarcoma Study Committee. Cancer 71 (1993) 2387
19. Hays D.M., Raney R.B., Wharam M.D., Wiener E., Lobe T.E., Andrassy R.J., et al. Children with vesical rhabdomyosarcoma (RMS) treated by partial cystectomy with neoadjuvant or adjuvant chemotherapy, with or without radiotherapy. A report from the Intergroup Rhabdomyosarcoma Study (IRS) Committee. J Pediatr Hematol Oncol 17 (1995) 46
20. Yeung C.K., Ward H.C., Ransley P.G., Duffy P.G., and Pritchard J. Bladder and kidney function after cure of pelvic rhabdomyosarcoma in childhood. Br J Cancer 70 (1994) 1000